EUVIMEDEUVIMED entdecken
Crossref

Sample sizes required to estimate the protective efficacy of a vaccine when there is an unequal allocation of individuals across the vaccine and placebo groups

Meghna Bose, Atanu Biswas iD

Statistical Methods in Medical Research · 2023

DOI: 10.1177/09622802231176807 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Statistical Methods in Medical Research, 2023. Verfasst von Meghna Bose und 1 weiteren Autor:innen. Beteiligte Einrichtung: Applied Statistics Unit, Indian Statistical Institute, Kolkata, India. Hauptthemen laut MEDLINE: Vaccine Efficacy, Vaccines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The effectiveness of a vaccine is measured by means of protective vaccine efficacy, defined by [Formula: see text], where [Formula: see text] and [Formula: see text] are, respectively, the disease attack rates in the vaccinated and the unvaccinated population. For each of the cohoret and case-control designs, methods have been presented in the literature for calculating the required sample size when the desired width of the confidence interval and the probability of coverage are pre-specified, where an equal number of individuals were assumed to be allocated to the vaccine and placebo group. In this article, we present a method for calculating the required sample size with a specified degree of precision when there is an unequal allocation of individuals across the two groups. The sample size required to achieve a desired power for the relevant level [Formula: see text] test has also been explored, keeping the unequal allocation proportion in mind. The fraction of individuals allocated to the placebo group ([Formula: see text]) can be so chosen that the total sample size or the expected number of people developing the disease or some other criteria of interest is minimized.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vaccine EfficacyVaccinesHumansSample SizePlacebosCase-Control StudiesModels, Statistical

Stichwörter der Autor:innen

Sample sizecohortdoubly biased coindesignrelative risksequential maximum likelihoodunequal allocationvaccine efficacy

Substanzen

PlacebosVaccines

Autor:innen und Institutionen

  • Applied Statistics Unit, Indian Statistical Institute, Kolkata, India.

ORCID-Profile: Atanu Biswas

Zitieren

APA

Bose, M., & Biswas, A. (2023). Sample sizes required to estimate the protective efficacy of a vaccine when there is an unequal allocation of individuals across the vaccine and placebo groups. Statistical Methods in Medical Research. https://doi.org/10.1177/09622802231176807

Vancouver

Bose M, Biswas A. Sample sizes required to estimate the protective efficacy of a vaccine when there is an unequal allocation of individuals across the vaccine and placebo groups. Statistical Methods in Medical Research. 2023. doi:10.1177/09622802231176807

BibTeX
@article{Bose2023,
  author = {Bose, Meghna and Biswas, Atanu},
  title = {Sample sizes required to estimate the protective efficacy of a vaccine when there is an unequal allocation of individuals across the vaccine and placebo groups},
  journal = {Statistical Methods in Medical Research},
  year = {2023},
  doi = {10.1177/09622802231176807}
}
Kostenlos starten →